First Trust Biotechnology Index Fund

FBT-N

NYSEARCA:FBT

174.53
1.55 (0.90%)

Analysis and Opinions about FBT-N

Signal
Opinion
Expert
PAST TOP PICK
PAST TOP PICK
August 4, 2017

(A Top Pick May 8/17. Up 11.02%.) The period of seasonal strength for this is usually early May right through until the middle of July. We have reached the point where seasonality no longer applies. Now is a good time to take the money off the table.

Show full opinionHide full opinion

(A Top Pick May 8/17. Up 11.02%.) The period of seasonal strength for this is usually early May right through until the middle of July. We have reached the point where seasonality no longer applies. Now is a good time to take the money off the table.

PAST TOP PICK
PAST TOP PICK
June 2, 2017

(A Top Pick May 8/17. Up 4%.) The biotech sector does very well at this time of year. This is because there are a number of healthcare conferences at this time of year, when all the major pharmaceutical and biotech companies come out with results of their research. This is still good until July.

Show full opinionHide full opinion

(A Top Pick May 8/17. Up 4%.) The biotech sector does very well at this time of year. This is because there are a number of healthcare conferences at this time of year, when all the major pharmaceutical and biotech companies come out with results of their research. This is still good until July.

TOP PICK
TOP PICK
May 8, 2017

This just broke into new highs a couple of days ago, so technically it looks good. Seasonally, the sector does very well from May right through until the middle of September. This is the time of year when you want to be in this kind of stock. In the short term, there is the ASCO conference coming up June 2-June 6. This is when a lot of the biotech companies come out with their new products from research. The stock got hammered today, because Pres. Trump called in all the big biotech CEOs, but it turned out they hadn’t talked about pricing at all. So, the weakness today is a buying opportunity.

Show full opinionHide full opinion

This just broke into new highs a couple of days ago, so technically it looks good. Seasonally, the sector does very well from May right through until the middle of September. This is the time of year when you want to be in this kind of stock. In the short term, there is the ASCO conference coming up June 2-June 6. This is when a lot of the biotech companies come out with their new products from research. The stock got hammered today, because Pres. Trump called in all the big biotech CEOs, but it turned out they hadn’t talked about pricing at all. So, the weakness today is a buying opportunity.

PAST TOP PICK
PAST TOP PICK
May 17, 2016

(A Top Pick April 12/16. Down 4.72%.) When the technicals come together, that is when you do a trade. In this particular case the technicals did not come into this particular investment, so it would have been better to hold off until the sector started to outperform the market.

Show full opinionHide full opinion

(A Top Pick April 12/16. Down 4.72%.) When the technicals come together, that is when you do a trade. In this particular case the technicals did not come into this particular investment, so it would have been better to hold off until the sector started to outperform the market.

TOP PICK
TOP PICK
April 12, 2016

Seasonality on this is from around the middle of April through until September. This has a lot to do with the large number of healthcare conferences being held in the summer. Technically it has already started an upward trend.

Show full opinionHide full opinion

Seasonality on this is from around the middle of April through until September. This has a lot to do with the large number of healthcare conferences being held in the summer. Technically it has already started an upward trend.

Showing 1 to 5 of 5 entries
  • «
  • 1
  • »

First Trust Biotechnology Index Fund(FBT-N) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for First Trust Biotechnology Index Fund is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

First Trust Biotechnology Index Fund(FBT-N) Frequently Asked Questions

What is First Trust Biotechnology Index Fund stock symbol?

First Trust Biotechnology Index Fund is a American stock, trading under the symbol FBT-N on the NYSE Arca (FBT). It is usually referred to as AMEX:FBT or FBT-N

Is First Trust Biotechnology Index Fund a buy or a sell?

In the last year, there was no coverage of First Trust Biotechnology Index Fund published on Stockchase.

Is First Trust Biotechnology Index Fund a good investment or a top pick?

First Trust Biotechnology Index Fund was recommended as a Top Pick by Don Vialoux on 2017-08-04. Read the latest stock experts ratings for First Trust Biotechnology Index Fund.

Why is First Trust Biotechnology Index Fund stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is First Trust Biotechnology Index Fund worth watching?

In the last year 0 stock analysts on Stockchase covered First Trust Biotechnology Index Fund. The stock is worth watching.

What is First Trust Biotechnology Index Fund stock price?

On 2020-07-08, First Trust Biotechnology Index Fund (FBT-N) stock closed at a price of $174.53.